Cite
HARVARD Citation
Asmus, E. et al. (2023). Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients. European respiratory journal. 61 (3), p. . [Online].